Showing results (1241-1250 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|September 28, 2024
Meta-analysis of platinum chemotherapy combinations with immunotherapy in metastatic urothelial carcinomaHatice Bolek, Satı Coskun Yazgan, Emre Yekedüz, et al.
The Oncologist|September 16, 2024
Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trialsWun-Ting Luo, Chia-Lun Chang, Tsai-Wei Huang, et al.
The Oncologist|September 22, 2024
Clinicopathologic and molecular characterization of stages II-IV gastric cancer with Claudin 18.2 expressionYoonjin Kwak, Tae-Yong Kim, Soo Kyung Nam, et al.
The Oncologist|March 3, 2024
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech RepublicZuzana Bielcikova, Milos Holanek, Iveta Selingerova, et al.
The Oncologist|March 4, 2024
Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With VismodegibSantiago Cabezas-Camarero, Vanesa García-Barberán, Rebeca Pérez-Alfayate, et al.
The Oncologist|March 7, 2024
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR)Kamal Kant Sahu, Haoran Li, Vinay Mathew Thomas, et al.
The Oncologist|February 20, 2024
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb TrialEmilio Bria, Floriana Morgillo, Marina Chiara Garassino, et al.
The Oncologist|February 23, 2024
Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in EthiopiaClara Yolanda Stroetmann, Muluken Gizaw, Rahel Alemayehu, et al.
The Oncologist|November 23, 2023
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL StudyAndrea Botticelli, Roberta Caputo, Simone Scagnoli, et al.
The Oncologist|November 16, 2023
Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint InhibitorsAdriana M Kahn, Curtis J Perry, Katrina Etts, et al.
Pageof 570